# | Title | Journal | Year | Citations |
---|
1 | Heart Failure | JACC: Heart Failure | 2013 | 612 |
2 | Impact of Obesity and the Obesity Paradox on Prevalence and Prognosis in Heart Failure | JACC: Heart Failure | 2013 | 463 |
3 | Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction | JACC: Heart Failure | 2016 | 390 |
4 | Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure | JACC: Heart Failure | 2013 | 337 |
5 | The Effect of Coenzyme Q 10 on Morbidity and Mortality in Chronic Heart Failure | JACC: Heart Failure | 2014 | 326 |
6 | Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction | JACC: Heart Failure | 2014 | 309 |
7 | The Transition From Hypertension to Heart Failure | JACC: Heart Failure | 2017 | 305 |
8 | Risk Prediction in Patients With Heart Failure | JACC: Heart Failure | 2014 | 303 |
9 | Pathogenic Gut Flora in Patients With Chronic Heart Failure | JACC: Heart Failure | 2016 | 293 |
10 | Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction | JACC: Heart Failure | 2018 | 290 |
11 | Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure | JACC: Heart Failure | 2018 | 272 |
12 | Developing Therapies for Heart Failure With Preserved Ejection Fraction | JACC: Heart Failure | 2014 | 267 |
13 | Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure | JACC: Heart Failure | 2015 | 265 |
14 | Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy | JACC: Heart Failure | 2017 | 262 |
15 | Cardiopulmonary Exercise Testing in Heart Failure | JACC: Heart Failure | 2016 | 258 |
16 | The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF | JACC: Heart Failure | 2018 | 254 |
17 | A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices | JACC: Heart Failure | 2017 | 248 |
18 | Factors Influencing the Predictive Power of Models for Predicting Mortality and/or Heart Failure Hospitalization in Patients With Heart Failure | JACC: Heart Failure | 2014 | 241 |
19 | Clinical Features, Hemodynamics, and Outcomes of Pulmonary Hypertension Due to Chronic Heart Failure With Reduced Ejection Fraction | JACC: Heart Failure | 2013 | 239 |
20 | Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction | JACC: Heart Failure | 2017 | 238 |
21 | Post-Myocardial Infarction Heart Failure | JACC: Heart Failure | 2018 | 237 |
22 | Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction | JACC: Heart Failure | 2017 | 236 |
23 | Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction | JACC: Heart Failure | 2020 | 208 |
24 | Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction | JACC: Heart Failure | 2015 | 204 |
25 | Clinical Implications of Intrarenal Hemodynamic Evaluation by Doppler Ultrasonography in Heart Failure | JACC: Heart Failure | 2016 | 202 |
26 | Iron Deficiency in Heart Failure | JACC: Heart Failure | 2019 | 195 |
27 | Acquired von Willebrand Syndrome in Patients With a Centrifugal or Axial Continuous Flow Left Ventricular Assist Device | JACC: Heart Failure | 2014 | 192 |
28 | Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice | JACC: Heart Failure | 2019 | 188 |
29 | HVAD: The ENDURANCE Supplemental Trial | JACC: Heart Failure | 2018 | 185 |
30 | Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction | JACC: Heart Failure | 2016 | 179 |
31 | Heart Failure and Atrial Fibrillation, Like Fire and Fury | JACC: Heart Failure | 2019 | 178 |
32 | Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices | JACC: Heart Failure | 2016 | 177 |
33 | The Burden of Acute Heart Failure on U.S. Emergency Departments | JACC: Heart Failure | 2014 | 176 |
34 | Hypertrophic Cardiomyopathy | JACC: Heart Failure | 2018 | 173 |
35 | Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure | JACC: Heart Failure | 2014 | 167 |
36 | The HVAD Left Ventricular Assist Device | JACC: Heart Failure | 2015 | 167 |
37 | Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock | JACC: Heart Failure | 2018 | 167 |
38 | Frailty and Healthcare Utilization Among Patients With Heart Failure in the Community | JACC: Heart Failure | 2013 | 166 |
39 | Prevalence and Prognostic Significance of Malnutrition Using 3 Scoring Systems Among Outpatients With Heart Failure | JACC: Heart Failure | 2018 | 166 |
40 | Cardiac Size and Sex-Matching in Heart Transplantation | JACC: Heart Failure | 2014 | 164 |
41 | The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries | JACC: Heart Failure | 2015 | 164 |
42 | Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure | JACC: Heart Failure | 2016 | 164 |
43 | The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma Patients | JACC: Heart Failure | 2013 | 163 |
44 | Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality | JACC: Heart Failure | 2020 | 163 |
45 | Heart Failure and Liver Disease | JACC: Heart Failure | 2019 | 162 |
46 | Cardiac Rehabilitation Exercise and Self-Care for Chronic Heart Failure | JACC: Heart Failure | 2013 | 161 |
47 | Frailty Is Intertwined With Heart Failure | JACC: Heart Failure | 2019 | 160 |
48 | Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients | JACC: Heart Failure | 2017 | 159 |
49 | A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation | JACC: Heart Failure | 2018 | 159 |
50 | Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure | JACC: Heart Failure | 2016 | 158 |